| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Revenue | $209.5M | +16.3% |
| Cost of Revenue | $25.0M | +13.0% |
| Gross Profit | $184.5M | +16.8% |
| R&D Expense | $70.6M | +10.2% |
| SG&A Expense | $50.6M | +18.7% |
| Operating Income | -$78.7M | +7.0% |
| Pre-tax Income | -$72.9M | +7.6% |
| Income Tax | $1.8M | +33.0% |
| Net Income | -$74.7M | +6.9% |
| EPS (Basic) | -$1.45 | +14.7% |
| EPS (Diluted) | -$1.45 | +14.7% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $30.5M | -26.2% |
| Short-term Investments | $116.6M | +3.9% |
| Accounts Receivable | $49.2M | +9.8% |
| Current Assets | $228.4M | +1.8% |
| Total Assets | $260.6M | +5.2% |
| Current Liabilities | $127.3M | +13.2% |
| Total Liabilities | $133.0M | +13.3% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.8M | +41.1% |
| Capital Expenditures | $3.0M | -35.9% |
| Investing Cash Flow | -$4.9M | -131.5% |
| Financing Cash Flow | $9.9M | -23.2% |
| Free Cash Flow | -$18.8M | +40.4% |
| Stockholders' Equity |
| $127.6M |
| -2.2% |